Dr. Yingtai Chen 陈应泰
Chief Physician
Department of Pancreatic and Gastric Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of gastric cancer, gastrointestinal stromal tumors, and pancreatic tumors, with a focus on minimally invasive techniques to reduce patient pain and improve quality of life.
Dr. Chen is a Chief Physician, Professor, and medical doctorate holder who completed postdoctoral research at Yale University. Dr. Chen serves as a master's supervisor at Peking Union Medical College. Clinical expertise includes surgical and minimally invasive treatment for gastric cancer, gastrointestinal stromal tumors, and pancreatic tumors.
Professional roles
- Standing Committee Member, Beijing Branch of Chinese Medical Association
- Secretary-General, Gastric Cancer Professional Committee, Beijing Anti-Cancer Association
- Chair, Young Physicians Committee, Beijing Translational Medicine Association
- Vice Chair, Tumor Prevention and Treatment Professional Committee, China National Health Association
Name order: in Chinese the family name comes first (Chen Yingtai). Papers usually list the name as Yingtai Chen or Chen Y.
Selected publications
100 papers on PubMed matched by name and affiliation; 32 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Lett, 2026 (senior author): Changing landscape in stage, treatment and survival of gastric cancer in China 1998-2022: Insights of 40,158 patients from the National Gastric Cancer Cohort. PubMed 41581644
- Cancer Rep (Hoboken), 2026 (senior author): Molecular Characteristics, Potential Mechanisms, and Prognostic Gene Model of Younger Female Patients With Gastric Cancer. PubMed 41773524
- Int J Surg, 2026 (senior author): Incidence, risk factors, recovery duration, and prognostic implications of gastroparesis following radical distal gastrectomy for gastric cancer: a large retrospective cohort study. PubMed 41549861
- BMC Cancer, 2025 (senior author): Heterogeneity of metastatic gastric cancer: solitary non-regional lymph node metastasis and solitary lung metastasis showed better survival outcomes than other metastatic patterns. PubMed 40781666
- J Glob Health, 2025 (senior author): Temporospatial variation in environmental risk factors and related gastric cancer incidence: a registry-based study in an area with the largest gastric cancer burden in China. PubMed 40452325
- Int J Surg, 2024 (senior author): Blood transfusion might not be recommended for gastric cancer patients with pretransfusion minimum hemoglobin values higher than 90 g/l: a real-world study covering 20 years of 13 470 patients. PubMed 38759693
- BMC Cancer, 2024 (senior author): Sex disparity, prediagnosis lifestyle factors, and long-term survival of gastric cancer: a multi-center cohort study from China. PubMed 39285317
- BMC Public Health, 2024 (senior author): Trends of older gastric cancer incidence, mortality, and survival in the highest gastric cancer risk area in China: 2010-2019 and prediction to 2024. PubMed 39251980
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion